ActiPatch® OTC Chronic Pain Therapy Overview

(4:21)

BioElectronics Corp. (BIEL) - New Developments in Pain Management NobleCon Online Investor Event

(38:38)

Andrew Whelan, CEO of BioElectronics, Discusses their New Pain Treatments without Medication

(15:48)

BioElectronics Corp's, CEO Andrew Whelan, New Pain Relief Product Gets FDA Approval

(18:21)

BioElectronics Corp (BIEL) CEO Andrew Whelan Discusses Non-invasive Electroceutical Medical Devices

(20:6)

This $0.006 Penny Stock has 240% Revenue Increase! Nobody talks about BioElectronics! BIEL Stock

(8:40)

BioElectronics ActiPatch® on Canadian News

(4:23)

CEOLIVE.TV Interview with BioElectronics (BIEL) VP, Dr. Deepak Kotak

(6:19)

Andrew Whelan CEO of BioElectronics Interviewed Live on Clear Channel The Traders Network Show

(19:37)

ActiPatch® OTC Chronic Pain Therapy Overview

(4:21)

Neurosoft Bioelectronics | Soft Implantable Electrodes to Interface with the Brain

(5:1econd)

CEO Andrew Whelan of BioElectronics Corp (OTC Pink BIEL)

(14:39)

ActiPatch® Pain Relief UK 60” Commercial Terri Oldacre December 2014

(1:11)

BioElectronics' Allay Mestrual Pain Product Explained

(2:37)

Bioelectronic Medicine

(4:5)

VP of Sales Keith Nalepka of BioElectronics Corp. (OTCPink: BIEL)

(12:22)

Andrew Whelan CEO of BioElectronics Interviewed Live on Clear Channel The Traders Network Show

(19:37)

Abbott Freestyle Libre 3 Review — A Discrete CGM For Diabetics

(4:14)

CEOLIVE.TV Interview | Dr. Deepak Kotak / Exec. VP of BioElectronics Corp. (OTC: BIEL)

(13:19)

Andrew J. Whelan, CEO, BioElectronics Corporation, Seg. 3 5/14/15 Live New Equity Network Show

(10:49)